Carnell Clint 4

Accession 0001181431-11-014260

CIK 0001171298other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 8:19 PM ET

Size

24.6 KB

Accession

0001181431-11-014260

Form 4

Period: 2011-02-25

Chief Operating Officer

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−49,999→ 150,001 total
Exercise: $1.91Exp: 2020-02-08→ Common Stock (49,999 underlying)
Exercise/Conversion
Common Stock
2011-02-25$1.00/sh+8,570$8,570→ 192,085 total
Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−88,930→ 97,500 total
Exercise: $1.00Exp: 2019-02-27→ Common Stock (88,930 underlying)
Exercise/Conversion
Common Stock
2011-02-28$1.00/sh+88,930$88,930→ 326,972 total
Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−75,332→ 0 total
Exercise: $1.90Exp: 2015-10-05→ Common Stock (75,332 underlying)
Sale
Common Stock
2011-02-28$3.16/sh−214,261$677,322→ 162,710 total
Sale
Common Stock
2011-02-25$3.13/sh−75,178$235,307→ 162,710 total
Exercise/Conversion
Common Stock
2011-02-28$1.90/sh+75,332$143,131→ 238,042 total
Exercise/Conversion
Common Stock
2011-02-28$1.91/sh+49,999$95,498→ 376,971 total
Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-25−8,570→ 186,430 total
Exercise: $1.00Exp: 2019-02-27→ Common Stock (8,570 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-25−45,803→ 75,332 total
Exercise: $1.90Exp: 2015-10-05→ Common Stock (45,803 underlying)
Exercise/Conversion
Common Stock
2011-02-25$1.90/sh+45,803$87,026→ 237,888 total

Footnotes (5)

[F1]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.18. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.25. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold
[F3]The option becomes exercisable according to the following schedule: 1/48 on 3/31/09 and 1/48 on the last day of each full calendar month thereafter.
[F4]The option is 100% vested and immediately exercisable.
[F5]The option becomes exercisable according to the following schedule: 1/48 on March 31, 2010 and 1/48 on the last day of each full calendar month thereafter.

Documents

1 file

SOLTA MEDICAL INC

CIK 0001171298

Entity typeother